These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35477503)

  • 1. Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia.
    Shayan S; Arashkia A; Bahramali G; Abdoli A; Nosrati MSS; Azadmanesh K
    Cancer Cell Int; 2022 Apr; 22(1):164. PubMed ID: 35477503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the Effects of
    Shayan S; Arashkia A; Bahramali G; Azadmanesh K
    Avicenna J Med Biotechnol; 2024; 16(2):120-129. PubMed ID: 38618508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia enhances the replication of oncolytic herpes simplex virus.
    Aghi MK; Liu TC; Rabkin S; Martuza RL
    Mol Ther; 2009 Jan; 17(1):51-6. PubMed ID: 18957963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic herpes simplex virus and immunotherapy.
    Ma W; He H; Wang H
    BMC Immunol; 2018 Dec; 19(1):40. PubMed ID: 30563466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
    Si YJ; Guang LX; Yuan FH; Zhang KB
    Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effect of dual fluorescent-labeled oncolytic herpes simplex virus type 1 on mouse tumorigenic cell lines.
    Abdoli S; Roohvand F; Teimoori-Toolabi L; Shayan S; Shokrgozar MA
    Res Pharm Sci; 2019 Feb; 14(1):27-35. PubMed ID: 30936930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of HSV-G47Δ Oncolytic Virus on Telomerase and Telomere Length Alterations in Glioblastoma Multiforme Cancer Stem Cells Under Hypoxia and Normoxia Conditions.
    Vazifehmand R; Ali DS; Homaie FM; Jalalvand FM; Othman Z; Deming C; Stanslas J; Sekawi Z
    Curr Cancer Drug Targets; 2024; 24(12):1262-1274. PubMed ID: 38357955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia Moderates γ(1)34.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary Cultures.
    Friedman GK; Haas MC; Kelly VM; Markert JM; Gillespie GY; Cassady KA
    Transl Oncol; 2012 Jun; 5(3):200-7. PubMed ID: 22741039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells.
    Sgubin D; Wakimoto H; Kanai R; Rabkin SD; Martuza RL
    Stem Cells Transl Med; 2012 Apr; 1(4):322-32. PubMed ID: 23197811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic cell death by oncolytic herpes simplex virus type 1 in squamous cell carcinoma cells.
    Takasu A; Masui A; Hamada M; Imai T; Iwai S; Yura Y
    Cancer Gene Ther; 2016 Apr; 23(4):107-13. PubMed ID: 26987291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia enhances the replication of oncolytic herpes simplex virus in p53- breast cancer cells.
    Fasullo M; Burch AD; Britton A
    Cell Cycle; 2009 Jul; 8(14):2194-7. PubMed ID: 19502787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema.
    Hong B; Muili K; Bolyard C; Russell L; Lee TJ; Banasavadi-Siddegowda Y; Yoo JY; Yan Y; Ballester LY; Bockhorst KH; Kaur B
    Mol Ther Oncolytics; 2019 Mar; 12():93-102. PubMed ID: 30719499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes Simplex Virus 1 Infection Promotes the Growth of a Subpopulation of Tumor Cells in Three-Dimensional Uveal Melanoma Cultures.
    Valyi-Nagy T; Fredericks B; Ravindra A; Hopkins J; Shukla D; Valyi-Nagy K
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy.
    Workenhe ST; Simmons G; Pol JG; Lichty BD; Halford WP; Mossman KL
    Mol Ther; 2014 Jan; 22(1):123-31. PubMed ID: 24343053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
    Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F
    Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell RNA sequencing reveals a strong connection between
    Ravirala D; Pei G; Zhao Z; Zhang X
    Mol Ther Oncolytics; 2021 Dec; 23():330-341. PubMed ID: 34786476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presage of oncolytic virotherapy for oral cancer with herpes simplex virus.
    Yura Y
    Jpn Dent Sci Rev; 2017 May; 53(2):53-60. PubMed ID: 28479936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-specific triple-regulated oncolytic herpes virus to target glioma.
    Delwar ZM; Liu G; Kuo Y; Lee C; Bu L; Rennie PS; Jia WW
    Oncotarget; 2016 May; 7(19):28658-69. PubMed ID: 27070093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo.
    Anesti AM; Simpson GR; Price T; Pandha HS; Coffin RS
    BMC Cancer; 2010 Sep; 10():486. PubMed ID: 20836854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway.
    Liu W; Zhang Z; Zhang Y; Chen X; Guo S; Lei Y; Xu Y; Ji C; Bi Z; Wang K
    Cancer Biol Ther; 2015; 16(4):511-7. PubMed ID: 25778491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.